We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Image Fusion PET, CT and 3D-ultrasound Examinations

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00302094
First Posted: March 13, 2006
Last Update Posted: December 3, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Caroline Ewertsen, Rigshospitalet, Denmark
March 10, 2006
March 13, 2006
December 3, 2012
June 2006
April 2009   (Final data collection date for primary outcome measure)
Program to fuse 3D ultrasound and PET/CT data [ Time Frame: april 2009 ]
Not Provided
Complete list of historical versions of study NCT00302094 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Image Fusion PET, CT and 3D-ultrasound Examinations
Image Fusion PET, CT and 3D-ultrasound Examinations in Treatment of Anal Cancer

CT-examinations are used in computer programs which are used in the planning of external radiation of cancers in the anal canal. In CT the structures of the anal canal are hardly visible. 3D-ultrasound examinations offer a better visualisation of normal and pathological structures of the anal canal. The description of the tumour made from the 3D-ultrasound examination is used in the planning of the external radiation.

PET-CT is used to visualise tumour activity also in lymp nodes. The hypothesis of the study is that image fusion of PET, CT and 3D-ultrasound will offer better visualisation of tumour and hereby more accurate diagnostics and treatment.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Patients with anal cancer
Anal Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
10
April 2009
April 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Histologically verified cancer of the anal canal

Exclusion Criteria:

  • Pregnancy
  • Unability to cooperate to radiation therapy
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Denmark
 
 
NCT00302094
(KF) 11-107/03
Not Provided
Not Provided
Not Provided
Caroline Ewertsen, Rigshospitalet, Denmark
Rigshospitalet, Denmark
Not Provided
Study Director: Michael B Nielsen, Dmsci, phd. Rigshospitalet, Denmark
Principal Investigator: Caroline Ewertsen, MD Rigshospitalet, Denmark
Rigshospitalet, Denmark
November 2012